Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy: Short report

British Journal of Haematology

Volumn 150, Issue 2, 2010, Pages 196-199

  Rosenberg, Philip S ^a   Zeidler, Cornelia ^b   Bolyard, Audrey A ^c   Alter, Blanche P ^a   Bonilla, Mary A ^d   Boxer, Laurence A ^e   Dror, Yigal ^f   Kinsey, Sally ^g   Link, Daniel C ^h   Newburger, Peter E ⁱ   Shimamura, Akiko ^j   Welte, Karl ^b   Dale, David C ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

acute myeloid leukaemia; granulocyte colony stimulating factor; myelodysplastic syndromes; severe congenital neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE SEVERITY; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEVERE CONGENITAL NEUTROPENIA; TREATMENT DURATION;

EPIDEMIOLOGIC METHODS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA;

EID: 77954324689     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08216.x     Document Type: Article

References (10)

1. Alter, B.P., Giri, N., Savage, S.A. Rosenberg, P.S. (2009) Cancer in dyskeratosis congenita. Blood, 113, 6549 6557.
2. Ancliff, P.J. (2003) Congenital neutropenia. Blood Reviews, 17, 209 216.
3. Dale, D.C. Link, D.C. (2009) The many causes of severe congenital neutropenia. New England Journal of Medicine, 360, 3 5.
4. Dale, D.C., Bonilla, M.A., Davis, M.W., Nakanishi, A.M., Hammond, W.P., Kurtzberg, J., Wang, W., Jakubowski, A., Winton, E. Lalezari, P. (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood, 81, 2496 2502.
5. Donadieu, J., Leblanc, T., Bader, M.B., Barkaoui, M., Fenneteau, O., Bertrand, Y., Maier-Redelsperger, M., Micheau, M., Stephan, J.L., Phillipe, N., Bordigoni, P., Babin-Boilletot, A., Bensaid, P., Manel, A.M., Vilmer, E., Thuret, I., Blanche, S., Gluckman, E., Fischer, A., Mechinaud, F., Joly, B., Lamy, T., Hermine, O., Cassinat, B., Bellanne-Chantelot, C. Chomienne, C. (2005) Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica, 90, 45 53.
6. Freedman, M.H., Bonilla, M.A., Fier, C., Bolyard, A.A., Scarlata, D., Boxer, L.A., Brown, S., Cham, B., Kannourakis, G., Kinsey, S.E., Mori, P.G., Cottle, T., Welte, K. Dale, D.C. (2000) Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood, 96, 429 436.
7. Gaynor, J.J., Feuer, E.J., Tan, C.C., Wu, D.H., Little, C.R., Strauss, D.J., Clarkson, B.D. Brennan, M.F. (1993) On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. Journal of the American Statistical Association, 88, 400 409.
8. Rosenberg, P.S. (1995) Hazard function estimation using B-splines. Biometrics, 51, 874 887.
9. Rosenberg, P.S., Greene, M.H. Alter, B.P. (2003) Cancer incidence in persons with Fanconi anemia. Blood, 101, 822 826.
10. Rosenberg, P.S., Alter, B.P., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Fier, C., Freedman, M., Kannourakis, G., Kinsey, S., Schwinzer, B., Zeidler, C., Welte, K. Dale, D.C. (2006) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood, 107, 4628 4635.